Publications by authors named "Jumi Han"

Claim this Profile
E
Effect of the sodium-glucose cotransporter-2 inhibitor, DWP16001, as an add-on therapy to insulin for diabetic dogs: A pilot study.
Ju-Hyun An, Han-Sol Choi, Ji-Soo Choi, Hyun-Woo Lim, Wan Huh, Jumi Han

Vet Med Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects.
Min Young Park, Sungyeun Bae, Jung A Heo, Mihee Park, YuKyung Kim, Jumi Han

Clin Transl Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19.
Yeon-Sook Kim, Seng-Ho Jeon, Junghee Kim, Jong Hoon Koh, Seung Won Ra, Sung-Han Kim, Jumi Han, Se Hee Han

Antimicrob Agents Chemother· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects.
Jun Gi Hwang, SeungHwan Lee, Wan Huh, Jumi Han, Jaeseong Oh

Br J Clin Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of safety and anti-obesity effects of DWP16001 in naturally obese dogs.
Beomseok Rhee, Rahman Md Mahbubur, Changfan Jin, Ji-Soo Choi, Hyun-Woo Lim, Jumi Han

BMC Vet Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial.
Muhammad Karyana, Irawaty Djaharuddin, Lutfah Rif'ati, Mansyur Arif, Mi Kyung Choi, Jumi Han

Stem Cell Res Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial.
Jae Hwan Cho, Jae Hyup Lee, Jin Sup Yeom, Bong-Soon Chang, Jae Jun Yang, Chang Ju Hwang, Jumi Han

Spine J· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis